Ravi Kushwaha
Overview
Explore the profile of Ravi Kushwaha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prasad N, Meyyappan J, Dhanorkar M, Kushwaha R, Mandal K, Veeranki V, et al.
Clin Kidney J
. 2024 Aug;
17(8):sfae218.
PMID: 39135934
Background: Idiopathic nephrotic syndrome (NS) in children poses treatment challenges, with a subset developing steroid-resistant nephrotic syndrome (SRNS). Genetic factors play a role, yet data on paediatric SRNS genetics in...
2.
Marak R, Abdullah , Behera M, Kaul A, Bhadauria D, Prasad N, et al.
Transpl Immunol
. 2024 Mar;
84:102041.
PMID: 38537681
Introduction: Kidney transplant recipients are at increased risk of opportunistic infections, including Nocardia. The incidence of nocardiosis in kidney transplant recipients is 0.4-1.3%. The data regarding its epidemiology and outcomes...
3.
Abdullah , Momin I, Kaul A, Bhadauria D, Prasad N, Behera M, et al.
Transpl Immunol
. 2024 Feb;
83:102012.
PMID: 38403198
Introduction: The incidence of post-transplant diabetes mellitus (PTDM) ranges from 2.5% to 20% in kidney transplant recipients. Diabetic retinopathy (DR), diabetic kidney disease (DKD), and distal symmetric polyneuropathy (DSPN) are...
4.
Kaul A, Pandey A, Behera M, Yachha M, Bhaduaria D, Patel M, et al.
J Assoc Physicians India
. 2023 Jun;
70(12):11-12.
PMID: 37355966
Introduction: The hemodynamic adjustments during pregnancy play a pivotal role in sustaining the gestation, however, its clinical connotation on midterm renal hyperfiltration and its consequence on maternal and fetal outcomes...
5.
Prasad N, Khurana M, Behera M, Yaccha M, Bhadauria D, Agarwal V, et al.
Indian J Nephrol
. 2023 May;
33(1):12-21.
PMID: 37197052
Introduction: Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis worldwide, but there is a marked geographic difference in its prevalence and prognosis. IgAN is known to have an aggressive...
6.
Prasad N, Veeranki V, Bhadauria D, Kushwaha R, Meyyappan J, Kaul A, et al.
J Clin Med
. 2023 Feb;
12(4).
PMID: 36836240
Background And Objectives: Owing to changing epidemiology and therapeutic practices, a change in the spectrum of renal involvement in Type-2 diabetes mellitus (T2DM) has also been noted. The treatment of...
7.
Prasad N, Khurana M, Kushwaha R, Patel M, Bhaduaria D, Kaul A, et al.
Int Urol Nephrol
. 2023 Feb;
55(7):1847-1855.
PMID: 36781681
Background: Diffuse crescentic IgAN (CIgAN) is an uncommon phenotype of IgAN, which presents as rapidly progressive renal failure, similar to patients with pauci-immune crescentic glomerulonephritis(PCGN). There are limited data on...
8.
Jose L, Kaul A, Bhadauria D, Kushwaha R, Nandan R, Lal H, et al.
Indian J Nephrol
. 2022 Dec;
32(5):430-434.
PMID: 36568600
Introduction: The most common complication of percutaneous renal biopsy is bleeding, which can be seen in up to one-third of cases. The aim of this study was to evaluate the...
9.
Kaul A, Bhaduaria D, Yachha M, Behera M, Kushwaha R, Prasad N, et al.
Indian J Nephrol
. 2022 Dec;
32(5):439-444.
PMID: 36568592
Introduction: Recent data suggest a risk of gestational hypertension, proteinuria and pre-eclampsia among pregnancies after kidney donation. Methods: This retrospective study among females who donated kidneys (1997-2017) at a tertiary...
10.
Chandrashekhar P, Kaul A, Bhaduaria D, Prasad N, Behera M, Kushwaha R, et al.
Transpl Infect Dis
. 2022 Oct;
24(6):e13963.
PMID: 36306185
Background: Rituximab is an anti-CD 20 agent used widely in renal transplant recipients. Its use is associated with various infections; however, its association with tuberculosis (TB) is not well established...